Patterns of viraemia in haemodialysis patients with hepatitis C
- PMID: 19259047
Patterns of viraemia in haemodialysis patients with hepatitis C
Abstract
Clinical features, aminotransferases levels, and antibody to HCV have only limited correlation with the activity of liver disease and cannot accurately predict persistence versus eradication of the virus in haemodialysis patients. Although permanent loss of serum HCV RNA appears to correlate with resolution of the disease, little is known about the predictive value of a single HCV RNA value. The aim of the study was to evaluate the viraemia in the serum of HCV antibody positive haemodialysis patients during a period of 3 years. The study group consisted of 65 HCV antibody positive patients from our dialysis unit. HCV antibodies were measured every 6 months by ELISA third-generation assay. The presence of serum HCV RNA was assessed by reverse-transcriptase polymerase chain reaction (RT-PCR) once a year during the period of 3 years. Serum levels of aminotransferases were measured monthly with standard automated analyzers. There were three different patterns of viraemia after the third assessment of the serum HCV RNA in HCV antibody positive patients: 47% (30/65) were persistently HCV RNA positive, 38% (25/65) were intermittently HCV RNA positive, and 15% (10/65) were persistently HCV RNA negative. The dominant genotype was 1a, detected in 97% of the patients positive for HCV RNA. The HCV RNA persistently positive patients had significantly higher levels of ALT compared to HCV RNA persistently negative patients (50.07 +/- 30.0 vs. 28.5 +/- 10.0 U/L, p < 0.027). There was no significant difference between the three groups of patients according to age, haemodialysis duration, and serum levels of AST. This pattern of intermittent viraemia clearly showed that a single negative result of the presence of serum HCV RNA in an HCV antibody positive patient should not be taken as a proof of a persistent resolution of HCV. Thus, repeated testing for HCV RNA is necessary to assess viraemia accurately in HCV antibody positive patients. HCV antibody positive patients who were persistently serum HCV RNA negative could be potentially infectious because of the possibility of the persistence of occult hepatitis C.
Similar articles
-
Biological dynamics of viral load in hemodialysis patients with hepatitis C virus.Am J Kidney Dis. 2000 Jan;35(1):122-9. doi: 10.1016/S0272-6386(00)70310-6. Am J Kidney Dis. 2000. PMID: 10620553
-
Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.Clin Nephrol. 1995 Jul;44(1):49-55. Clin Nephrol. 1995. PMID: 7554533
-
Hepatitis C viral infection in a Chinese hemodialysis unit.Chin Med J (Engl). 2010 Dec;123(24):3574-7. Chin Med J (Engl). 2010. PMID: 22166633
-
Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.Nephrol Dial Transplant. 2011 Aug;26(8):2648-56. doi: 10.1093/ndt/gfq757. Epub 2011 Jan 27. Nephrol Dial Transplant. 2011. PMID: 21273235
-
Hepatitis C Antibody Positive, RNA Negative.Clin Liver Dis (Hoboken). 2019 Aug 2;14(1):5-7. doi: 10.1002/cld.755. eCollection 2019 Jul. Clin Liver Dis (Hoboken). 2019. PMID: 31391928 Free PMC article. Review. No abstract available.
Cited by
-
Management of hepatitis C in patients with chronic kidney disease.World J Gastroenterol. 2015 Jan 14;21(2):408-22. doi: 10.3748/wjg.v21.i2.408. World J Gastroenterol. 2015. PMID: 25593456 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical